EUVIMEDEUVIMED entdecken
Crossref

Hypoglycemic effect of intranasally delivered insulin improved with coadministrated novel cell-penetrating peptides

Panfeng Yin, Minglu Sun, Si Chen, Xianchun Wang iD

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgaf126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Panfeng Yin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Protein Chemistry Laboratory, College of Life Sciences, Hunan Normal University, 36 Lushan Road, Yuelu District, Changsha 410081, Hunan, China. Hauptthemen laut MEDLINE: Insulin, Hypoglycemic Agents, Cell-Penetrating Peptides, Blood Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Latroeggtoxin-VI (LETX-VI) was previously shown to cross cell membrane and its C-terminal sequence is the functional peptide segment (FPS) for the transmembrane action. This proof-of-concept study aimed to confirm the promoting-effect of FPS as well as LETX-VI on nasal insulin absorption.

Methods

After FPS and LETX-VI were intranasally coadministrated with insulin to mice, respectively, the changes in hypoglycemic effect of the insulin were determined.

Results

Compared with insulin alone, the mixture of insulin and 0.5 mM LETX-VI decreased the peak blood glucose concentration by 33.14% (P < .05); coadministration of insulin and 4 mM FPS decreased the peak value of blood glucose by 19.88% (P < .05). Besides, addition of 4 mM FPS decreased the AUC0–90 min value from 1062.50 of insulin alone to 926.17, which was significantly lower than that of the blank control (P < .05); FPS made the insulin exert hypoglycemic effect earlier and did not change the end time of the hypoglycemic action.

Conclusion

Both LETX-VI and FPS are able to efficiently facilitate nasal insulin absorption and thus enhance the hopyglycemic effect of insulin. Relatively, FPS has a much smaller molecular weight and thus is more promising in the transmembrane delivery of drugs including insulin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinHypoglycemic AgentsCell-Penetrating PeptidesBlood GlucoseAnimalsAdministration, IntranasalMiceMaleProof of Concept StudyDrug Delivery Systems

Stichwörter der Autor:innen

blood glucosecell-penetrating peptidefunctional peptide segmentinsulinintranasal coadministrationlatroeggtoxin-VI

Substanzen

InsulinHypoglycemic AgentsCell-Penetrating PeptidesBlood Glucose

Autor:innen und Institutionen

  • Protein Chemistry Laboratory, College of Life Sciences, Hunan Normal University, 36 Lushan Road, Yuelu District, Changsha 410081, Hunan, China.

ORCID-Profile: Xianchun Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yin, P., Sun, M., Chen, S., & Wang, X. (2025). Hypoglycemic effect of intranasally delivered insulin improved with coadministrated novel cell-penetrating peptides. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf126

Vancouver

Yin P, Sun M, Chen S, Wang X. Hypoglycemic effect of intranasally delivered insulin improved with coadministrated novel cell-penetrating peptides. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf126

BibTeX
@article{Yin2025,
  author = {Yin, Panfeng and Sun, Minglu and Chen, Si and Wang, Xianchun},
  title = {Hypoglycemic effect of intranasally delivered insulin improved with coadministrated novel cell-penetrating peptides},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgaf126}
}
Kostenlos starten →